| http://dbpedia.org/ontology/abstract
|
Fontolizumab (planned trade name HuZAF) is … Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.the first phase did not meet the endpoint.
, فونتوليزوماب هو جسم مضاد وحيد النسيلة مأنسن وهو دواء كبت مناعة يستخدم لعلاج أمراض المناعة الذاتية مثل داء كرون. أوقفت المرحلة الثانية من التجارب السريرية لاستخدامه في علاج التهاب المفاصل الروماتويدي لأن المرحلة الأولى لم تصل إلى نقطة نهاية.
, Il fontolizumab nome commerciale HuZAF, è … Il fontolizumab nome commerciale HuZAF, è un anticorpo monoclonale di tipo murino umanizzato, che viene utilizzato per il trattamento di malattie autoimmuni come la malattia di Crohn e l'artrite reumatoide. Il farmaco agisce sul interferone gamma. Esso è sviluppato dalla .terferone gamma. Esso è sviluppato dalla .
|
| http://dbpedia.org/ontology/casNumber
|
326859-36-3
|
| http://dbpedia.org/ontology/fdaUniiCode
|
6J92H2439Z
|
| http://dbpedia.org/ontology/kegg
|
D04242
|
| http://dbpedia.org/ontology/wikiPageID
|
9134121
|
| http://dbpedia.org/ontology/wikiPageLength
|
2551
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
977249694
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Interferon_gamma +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Crohn%27s_disease +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Immunosuppressive_drug +
, http://dbpedia.org/resource/Auto-immune_disease +
, http://dbpedia.org/resource/Humanized_monoclonal_antibody +
, http://dbpedia.org/resource/Clinical_endpoint +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/casNumber
|
326859
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/kegg
|
D04242
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/molecularWeight
|
ca. 150 kg/mol
|
| http://dbpedia.org/property/source
|
zu/o
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/Interferon_gamma +
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
6
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
457119389
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Keggcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Antineoplastic-drug-stub +
, http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Cytokine_receptor_modulators +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Monoclonals_for_immune_system +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Immunosuppressants +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Fontolizumab?oldid=977249694&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Fontolizumab +
|
| owl:sameAs |
http://rdf.freebase.com/ns/m.027yypn +
, https://global.dbpedia.org/id/3TqVH +
, http://ar.dbpedia.org/resource/%D9%81%D9%88%D9%86%D8%AA%D9%88%D9%84%D9%8A%D8%B2%D9%88%D9%85%D8%A7%D8%A8 +
, http://yago-knowledge.org/resource/Fontolizumab +
, http://dbpedia.org/resource/Fontolizumab +
, http://it.dbpedia.org/resource/Fontolizumab +
, http://www.wikidata.org/entity/Q3747524 +
|
| rdf:type |
http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Antibody115027189 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
Fontolizumab (planned trade name HuZAF) is … Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.the first phase did not meet the endpoint.
, فونتوليزوماب هو جسم مضاد وحيد النسيلة مأنسن وهو دواء كبت مناعة يستخدم لعلاج أمراض المناعة الذاتية مثل داء كرون. أوقفت المرحلة الثانية من التجارب السريرية لاستخدامه في علاج التهاب المفاصل الروماتويدي لأن المرحلة الأولى لم تصل إلى نقطة نهاية.
, Il fontolizumab nome commerciale HuZAF, è … Il fontolizumab nome commerciale HuZAF, è un anticorpo monoclonale di tipo murino umanizzato, che viene utilizzato per il trattamento di malattie autoimmuni come la malattia di Crohn e l'artrite reumatoide. Il farmaco agisce sul interferone gamma. Esso è sviluppato dalla .terferone gamma. Esso è sviluppato dalla .
|
| rdfs:label |
فونتوليزوماب
, Fontolizumab
|
